Cargando…
Rapamycin does not inhibit human cytomegalovirus reactivation from dendritic cells in vitro
Human cytomegalovirus (HCMV) infection and reactivation are a major cause of morbidity in immune-suppressed patients. Interestingly, epidemiological studies have shown that patients administered the mammalian target of rapamycin (mTOR) inhibitor, sirolimus (rapamycin), exhibit more favourable outcom...
Autores principales: | Glover, Thomas E., Kew, Verity G., Reeves, Matthew B. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Society for General Microbiology
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4165932/ https://www.ncbi.nlm.nih.gov/pubmed/24986086 http://dx.doi.org/10.1099/vir.0.066332-0 |
Ejemplares similares
-
Identification and characterization of bisbenzimide compounds that inhibit human cytomegalovirus replication
por: Falci Finardi, Nicole, et al.
Publicado: (2021) -
A Virally Encoded DeSUMOylase Activity Is Required for Cytomegalovirus Reactivation from Latency
por: Poole, Emma L., et al.
Publicado: (2018) -
Mitogen and Stress Activated Kinases Act Co-operatively with CREB during the Induction of Human Cytomegalovirus Immediate-Early Gene Expression from Latency
por: Kew, Verity G., et al.
Publicado: (2014) -
A temperature-dependent virus-binding assay reveals the presence of neutralizing antibodies in human cytomegalovirus gB vaccine recipients’ sera
por: Gomes, Ariane C., et al.
Publicado: (2023) -
Human cytomegalovirus suppresses Fas expression and function
por: Seirafian, Sepehr, et al.
Publicado: (2014)